20 Mycobacteria

download 20 Mycobacteria

of 47

Transcript of 20 Mycobacteria

  • 7/26/2019 20 Mycobacteria

    1/47

    Mycobacteria

    MICROBIOLOGY LECTURE SERIES

    LUZ GREGORIA LAZO-VELASCO, MD

  • 7/26/2019 20 Mycobacteria

    2/47

    Mycobacteria Rod-shaped, aerobic bacteria

    do NOT form spores

    acid-fast bacilli

    do not stain readily but once stained, resist

    decolorization by acid or alcohol

    Mycobacterium tuberculosis tuberculosis

    Mycobacterium leprae leprosy

    Mycobacterium avium- intracellulare (M. avium complex,or MAC) /other nontuberculous mycobacteria (NTM) -

    infect patients w/ AIDS; opportunistic pathogens in other

    immunocompromised persons; occasionally cause disease

    in patients with normal immune system

  • 7/26/2019 20 Mycobacteria

    3/47

    MycobacteriaSPECIES RESERVOIR COMMON CLINICAL MANIFESTATION;COMMENT

    SPECIES ALWAYS CONSIDERED PATHOGENS

    M. tuberculosis Humans Pulmonary and disseminated TB

    M. leprae Humans Leprosy

    M. bovis Humans, cattle Tuberculosis-like diseaseClosely related to M. tuberculosis

    SPECIES POTENTIALLY PATHOGENIC IN HUMANS

    MODERATELY COMMON CAUSES OF DISEASE

    M. avium

    complex

    Soil, water, birds,

    fowl, swine, cattle,envt.

    Disseminated, pulmonary; very common in AIDS

    pts.; occurs in other immunosuppressed pts.Uncommon in pts w/ normal immune system

    M. kansasii Water, cattle Pulmonary, other sites

  • 7/26/2019 20 Mycobacteria

    4/47

  • 7/26/2019 20 Mycobacteria

    5/47

    MORPHOLOGY AND IDENTIFICATION

    A. TYPICAL ORGANISM

    characterized by acid-fastness (95% ethyl alcohol

    containing 3% hydrochloric acid/acid-alcohol quicklydecolorizes all bacteria EXCEPT mycobacteria)

    acid fastness depends on integrity of waxy envelope

    Yellow-orange fluorescence with fluorochrome stain

    (auramine, rhodamine)

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    6/47

    Acid-Fast Stains

    (Ziehl-Neelsen) Principle

    The lipid capsule of the acid fast bacteria contains mycolic acid(long chain fatty acid) which is responsible for its waxycharacteristic that resists the penetration of an aqueous based

    solution (i.e. Crystal violet). The lipid capsule takes up thecarbolfuchsin and resists decolorization with an acid alcoholrinse.

    Primary Stain: Carbolfuchsin

    lipid-soluble and contains phenol, which helps the stain penetrate

    the cell wall; assisted by the addition of heat Smear is rinsed with a very strong decolorizer, which strips the

    stain from all non-acid-fast cells but does not permeate thecell wall of acid-fast organisms

    The decolorized non-acid-fast cells then take up the

    counterstain.

  • 7/26/2019 20 Mycobacteria

    7/47

    Counter Stain: Methylene Blue

    Malachite Green

    Acid-Fast Stains

    (Ziehl-Neelsen)

  • 7/26/2019 20 Mycobacteria

    8/47

    MORPHOLOGY AND IDENTIFICATION

    B. CULTURE

    media for primary culture:

    nonselective mediumselective medium- antibiotics to prevent the overgrowth

    of contaminating bacteria and fungi

    1. Semisynthetic Agar media

    2. Inspissated Egg Media3. Broth Media

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    9/47

    MORPHOLOGY AND IDENTIFICATION

    B. CULTURE

    1. SEMISYNTHETIC AGAR MEDIA

    Middlebrook 7H10 and 7H11 contain:

    - defined salts - cofactors - albumin - glycerol

    - vitamins - oleic acid - catalase

    7H11 medium (+) casein hydrolysateused for observing colony morphology, susceptibility

    testing, as selective media (add antibiotics)

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    10/47

    MORPHOLOGY AND IDENTIFICATION

    B. CULTURE

    2. INSPISSATED EGG MEDIA

    Lwenstein-Jensen contain:- defined salts - complex organic substances

    - glycerol (fresh eggs or egg yolks, potato flour)

    - MALACHITE GREEN (inhibit other bacteria)

    small inocula in specimens will grow on these media in 3-6

    wks

    serve as selective media (antibiotics added)

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    11/47

    MORPHOLOGY AND IDENTIFICATION

    B. CULTURE

    3. BROTH MEDIAMiddlebrook 7H9 and 7H12

    - support proliferation of small inocula

    - ordinarily, mycobacteria grow in clumps or masses

    (hydrophobic character of cell surface)- growth is more rapid than on complex media

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    12/47

    Culture of M. tuberculosis on egg nutrient substrate:

    after four weeks of incubation- rough, yellowish, cauliflowerlike colonies

  • 7/26/2019 20 Mycobacteria

    13/47

    MORPHOLOGY AND IDENTIFICATION

    C. GROWTH CHARACTERISTICS

    obligate aerobes

    derive energy from oxidation of many simple carboncompounds

    increased CO2 tension enhances growth

    biochemical activities are not characteristic

    growth rate is much slower than that of most bacteria

    doubling time: 18hrs

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    14/47

    MORPHOLOGY AND IDENTIFICATION

    D. REACTION TO PHYSICAL AND CHEMICAL AGENTS

    more resistant to chemical agents than other bacteria

    (hydrophobic nature of cell surface and their clumped

    growth)

    dyes (malachite green) and antibacterial agents (penicillin)

    can be incorporated into media without inhibiting the

    growth of tubercle bacilli

    acids and alkalies permit the survival of some exposedtubercle bacilli; used to help eliminate contaminating

    organisms and for concentration of clinical specimens

    resistant to drying and survive long periods in dried sputum

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    15/47

    MORPHOLOGY AND IDENTIFICATION

    E. PATHOGENICITY OF MYCOBACTERIA

    Humans and guinea pigs highly susceptible to M. tuberculosis

    infection; fowls and cattle are resistant

    M. tuberculosis and M. bovis are equally pathogenic to

    humans

    route of infection (resp. vs. intestinal) determines the pattern

    of lesions

    Some atypical mycobacteria (nontuberculous)

    M. kansasiiproduce human disease indistiguishable from

    tuberculosis

    others cause only surface lesions or act as opportunists

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    16/47

    Constituents of Tubercle bacilli

    1. Lipids- largely bound to proteins & polysaccharides

    - mycolic acids (long-chain FA C78-C90)

    - waxes

    - phosphatides

    Muramyl dipeptide complexed with mycolic acids -

    granuloma formation

    Phospholipids caseous necrosis

    Lipids responsible for acid-fastness

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    17/47

    Constituents of Tubercle bacilli

    1. Lipids

    Virulent strains of tubercle bacilli form microscopic

    serpentine cords (acid-fast bacilli are arranged in parallel

    chains) related to virulence

    Cord factor (trehalose-6,6 dimycolate) extracted

    from virulent bacilli; inhibits migration of leukocytes, causes

    chronic granulomas, serve as immunologic adjuvant

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    18/47

    Constituents of Tubercle bacilli

    2. Proteins elicit the tuberculin reaction; elicit formation

    of a variety of antibodies

    3. Polysaccharides role in pathogenesis of disease

    uncertain; induce immediate type of hypersensitivity;

    serve as antigens in reactions with sera of infected

    persons

    Mycobacterium tuberculosis

  • 7/26/2019 20 Mycobacteria

    19/47

    Pathogenesis

    Mycobacteria emitted in droplets

  • 7/26/2019 20 Mycobacteria

    20/47

    PathologyProduction and development of lesions and healing or

    progression determined by:

    1. number of mycobacteria in inoculum and their

    subsequent multiplication

    2. type of host (resistance and hypersensitivity)

  • 7/26/2019 20 Mycobacteria

    21/47

    Pathology

    PRINCIPAL LESIONS

    Exudative type

    Acute inflammatory reaction, with edema fluid, PMN

    leukocytes, and monocytes around tubercle bacilliSeen in lung tissue resembling bacterial pneumonia

    May: heal by resolution

    lead to massive necrosis of tissue

    develop to second (productive) type of lesions

    tuberculin test positive

  • 7/26/2019 20 Mycobacteria

    22/47

    Pathology

    PRINCIPAL LESIONS

    Productive type

    Chronic granuloma with 3 zones:

    1. CENTRAL AREA of large, multinucleated giant cellscontaining tubercle bacilli

    2. MID ZONE of pale epithelioid cells

    3. PERIPHERAL ZONE of fibroblasts, lymphocytes and

    monocytes

    Later, peripheral fibrous tissue develops and central area

    undergoes caseation necrosis

    Caseous tubercle may break into a bronchus, empty itself and

    form a cavity

    Heal by fibrosis or calcification

  • 7/26/2019 20 Mycobacteria

    23/47

    Pathology

    SPREAD OF ORGANISMS IN THE HOST

    - direct extension through lymphatic channels and

    bloodstream

    - via bronchi and GI tract

    - in first infection, tubercle bacilli always spread from the

    initial site via lymphatics to regional lymph node

    - bacilli may spread farther and reach the bloodstream

    distributes bacilli to all organs (miliary distribution)

    - bloodstream can be invaded also by erosion of a vein or

    caseating tubercle or lymph node

  • 7/26/2019 20 Mycobacteria

    24/47

    PathologyINTRACELLULAR SITE OF GROWTH- Once mycobacteria establish themselves in tissue, they reside

    principally intracellularly in:

    monocytes giant cells

    reticuloendothelial cells- INTRACELLULAR LOCATION makes chemotherapy difficult and

    favors microbial persistence

  • 7/26/2019 20 Mycobacteria

    25/47

    Primary Infection of Tuberculosis

    when a host has first contact with tubercle bacilli, the

    following features are observed:

    1. acute exudative lesion develops and rapidly spreads to

    lymphatics and regional lymph nodes

    2. lymph node undergoes massive caseation, usually calcifies(Ghon lesion)

    3. tuberculin test becomes positive

    Primary infection type: past (childhood) now in adults who

    have remained free from infection (tuberculin-negative) inearly life

    Involves any part of the lung , most often the base

  • 7/26/2019 20 Mycobacteria

    26/47

    Reactivation Type of Tuberculosis

    - usually caused by tubercle bacilli that survived in the primarylesion

    - characterized by:

    1. chronic tissue lesion

    2. tubercle formation

    3. caseation

    4. fibrosis

    - Regional LN slightly involved, do not caseate

    - almost always begins at the APEX of lung, where oxygen tension

    is highest- differences between primary infection and reinfection/

    reactivation is attributed to:

    1. resistance

    2. hypersensitivity induced by first infection

  • 7/26/2019 20 Mycobacteria

    27/47

    Immunity and

    Hypersensitivity

    During the first infection with tubercle bacilli, certain

    resistance is acquired and there is increased capacity to

    localize tubercle bacilli, retard their multiplication, limit

    their spread, reduce lymphatic dissemination

    (cellular immunity)

    In the course of primary infection, host also acquires

    HYPERSENSITIVITY to tubercle bacilli (positive tuberculin

    reaction)

  • 7/26/2019 20 Mycobacteria

    28/47

    Tuberculin test

    A. MATERIAL

    Old tuberculin (concentrated filtrate of broth in

    which tubercle bacilli have grown for 6 weeks)

    PPD - obtained by chemical fractionation of old

    tuberculin

    B. DOSE OF TUBERCULIN

    5 TU , 1 TU (extreme hypersensitivity)

    0.1mL injected intracutaneously

  • 7/26/2019 20 Mycobacteria

    29/47

    Tuberculin test

    C. REACTIONS TO TUBERCULIN

    examined for presence of induration no later than 72 hrs

    POSITIVE: induration of > 10mm in diameter

    >5mm in pts at highest risk of developingactive disease (HIV-infected, + exposure)

    > 15mm in persons with low risk

  • 7/26/2019 20 Mycobacteria

    30/47

    Tuberculin test

    C. REACTIONS TO TUBERCULIN- tuberculin test becomes positive w/in 4-6

    weeks after infection

    - may be negative in the presence of tuberculousinfection when anergy develops due to:

    overwhelming tuberculosis

    measles

    Hodgkins disease

    Sarcoidosis

    AIDS or immunosuppression

  • 7/26/2019 20 Mycobacteria

    31/47

    Tuberculin test

    C. REACTIONS TO TUBERCULIN

    Positive tuberculin test indicates that and

    individual has been infected in the past

    it does NOT imply that an active disease or

    immunity to disease is present

  • 7/26/2019 20 Mycobacteria

    32/47

    Tuberculin test

    D. INTERFERON-GAMMA RELEASE ASSAYS FORDETECTION OF TUBERCULOSIS

    - improve diagnostic accuracy

    - whole-blood gamma-interferon release assays (IGRAs)

    - based on the hosts immune responses to specificM tuberculosis antigens ESAT-6 (early secretory antigenictarget-6) & CFP-10 (culture filtrate protein-10) which areabsent from NTM mycobacteria & BCG

    - detects interferon-gamma released by sensitized CD4 T cells in

    response to these antigens- Commercial assays (US): QFT-GIT (Quantiferon-Gold In-Tube

    Test), T-SPOT-TB

  • 7/26/2019 20 Mycobacteria

    33/47

    Clinical Findings

    can involve every organ system, its clinical manifestations

    are protean

    fatigue, weakness, weight loss, fever, night sweats

    pulmonary involvement (chronic cough and spitting of

    blood) is associated with far-advanced lesions

    meningitis/ urinary tract involvement can occur in the

    absence of other signs of TB

    bloodstream dissemination leads to miliary TB with

    lesions in many organs and a high mortality rate

  • 7/26/2019 20 Mycobacteria

    34/47

    Diagnostic Laboratory Tests

    positive tuberclin test does NOT prove the presence of

    active disease due to tubercle bacilli

    Isolation of tubercle bacilli provides proof

    Specimens:

    fresh sputum gastric washings

    urine blood

    joint fluid pleural fluid

    biopsy material CSFother suspected material

  • 7/26/2019 20 Mycobacteria

    35/47

    Diagnostic Laboratory Tests

    SMEARS

    - Sputum, exudates or other material is examined for acid fast

    bacilli by (Ziehl-Neelsen) staining

    - Stains of gastric washings and urine generally are NOTrecommended because saprophytic bacteria may be present

    and yield a positive stain

    - Fluorescence microscopy (auramine-rhodamine stain) ismore sensitive than acid fast stain; preferred method for

    clinical material

  • 7/26/2019 20 Mycobacteria

    36/47

    Diagnostic Laboratory Tests Culture, Identification and Susceptibility testing

    - selective broth culture - most sensitive method and provides

    results more rapidly (Lowenstein-Jensen, Middlebrook

    7H10/H11 biplate with antibiotics)

    - incubated at 35-37

    o

    C in 5-10% CO2 for up to 8weeks- Blood for culture of mycobacteria (MAC) should be

    anticoagulated and processed by 1 of 2 methods:

    1. commercially available lysis centrifugation system

    2. inoculation into commercially available broth mediaspecifically designed for blood cultures

  • 7/26/2019 20 Mycobacteria

    37/47

  • 7/26/2019 20 Mycobacteria

    38/47

    Diagnostic Laboratory Tests

    Culture, Identification and Susceptibility testing Growth rates separates the rapid growers (growth in < 7

    days) from other mycobacteria

    Photochromogens produce pigments in light but not

    in darkness Scotochromogens develop pigment when growing

    in the dark

    Nonchromogen (nonphotochromogen) are nonpigmented

    or have light tan or buff-colored colonies

  • 7/26/2019 20 Mycobacteria

    39/47

    CLASSIFICATION ORGANISM

    TUBERCULOSIS COMPLEX - M. tuberculosis

    - M. africanum- M. bovis

    PHOTOCHROMOGENS - M. asiaticum

    - M. kansasii

    - M. marinum

    - M. simiae

    SCOTOCHROMOGENS - M. flavescens

    - M. gordonae- M. scrofulaceum

    - M. szulgai

    TRADITIONAL RUNYON CLASSIFICATION OF MYCOBACTERIA

  • 7/26/2019 20 Mycobacteria

    40/47

    NONCHROMOGENS -M. avium complex - M. celatum

    - M. haemophilum - M. gastri

    - M. genavense - M. malmoense- M nonchromogenicum

    - M. shimoidei - M. terrae

    - M. trivale - M. ulcerans

    - M. xenopiRAPID GROWERS - M. abscessus

    - M. fortuitum group

    - M. chelonae group

    - M. immunogenum- M. mucogenicum

    - M. phlei

    - M. smegmatis

    - M. vaccae

    TRADITIONAL RUNYON CLASSIFICATION OF MYCOBACTERIA

  • 7/26/2019 20 Mycobacteria

    41/47

    Diagnostic Laboratory Tests

    Culture, Identification and Susceptibility testing Molecular probe methods faster than conventional

    methods

    High Performance Liquid Chromatography (HPLC)

    - based on development of profiles of mycolic acids whichvary from one species to another

    MALDI-TOF-MS (Matrix-assisted laser desorption ionization-

    time of flight mass spectrometry) not useful

    Susceptibility Testing - adjunct in selecting drugs for effectivetherapy

  • 7/26/2019 20 Mycobacteria

    42/47

    Diagnostic Laboratory Tests

    DNA detection

    Polymerase chain reaction - rapid and direct detection of

    M. tuberculosis in clinical specimens

    - overall sensitivity: 55-90%; specificity: 99%- highest sensitivity when applied to specimens that have

    smear positive for acid-fast bacilli

    DNA fingerprinting - done using standardized protocol based

    on restriction fragment length polymorphism- DNA fragments are generated by restriction

    endonuclease digestion and separated by electrophoresis

  • 7/26/2019 20 Mycobacteria

    43/47

  • 7/26/2019 20 Mycobacteria

    44/47

    Treatment

    4-drug regimen: INH, RFM, PZA, EMB

    Multidrug-resistant M tuberculosis

    resistant to both INH, RMP

    treated according to susceptibility tests Extensively drug-resistant (XDR)

    resistant to both INH, RMP, any fluoroquinolone,

    and at least one of the three injectable 2nd

    line drugs (amikacin, capreomycin,kanamycin)

  • 7/26/2019 20 Mycobacteria

    45/47

    Epidemiology

    most frequent source of infection is the human who excretes,particularly from the respiratory tract, large numbers of

    tubercle bacilli

    Close contact (in the family)

    Massive exposure (in medical personnel)

    Development of clinical disease influenced by:

    - age (high risk in infancy and in the elderly)

    - undernutrition

    - immunologic status

    - coexisting disease (silicosis, diabetes)

  • 7/26/2019 20 Mycobacteria

    46/47

    Prevention and Control

    Prompt and effective treatment of patients with active

    tuberculosis and careful follow-up of their contacts with

    tuberculin tests, x-rays, and appropriate treatment are

    the mainstays of public health tuberculosis control

    Drug treatment of asymptomatic tuberculin-positive

    persons in the age groups most prone to develop

    complications (children) and in tuberculin-positive

    persons who must receive immunosuppressive drugs

    greatly reduces reactivation of infection

    P ti d C t l

  • 7/26/2019 20 Mycobacteria

    47/47

    Prevention and Control Individual host resistance: nonspecific factors may reduce

    host resistance, thus favouring the conversion ofasymptomatic infection into a disease

    - factors: starvation, gastrectomy, and suppression of cellularimmunity by drugs (corticosteroid) or infection, HIV infectionis a major risk factor for tuberculosis

    Immunization: various living avirulent tubercle bacilli,particularly BCG (bacillus-calmette-guerin, an attenuatedbovine organism), have been used to induced certain amountof resistance in those heavily exposed to infection.

    The eradication of tuberculosis in cattle and thepasteurization of milk have greatly reduced M bovis infection